Back to 
CAPTRUST FINANCIAL ADVISORS
CAPTRUST FINANCIAL ADVISORS
NGENShowing 2 of 6 quarters
Position history for CAPTRUST FINANCIAL ADVISORS's holdings in NERVGEN PHARMA CORP
Yes. Captrust holds 64,423 shares of NGEN (Nervgen Pharma), worth $132,711, as of its Q2 2026 13F filing. It increased the position by 2,056 shares (+3.3%) from Q1 2026. Captrust has held NGEN in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$132,711
Current Shares
64,423
Total Value Change
-$102,413
Total Shares Change
+2,056
Quarter-by-Quarter History
Other major holders of NGEN: LMR Partners LLP, MARSHALL WACE, LLP, UBS Group AG, BANK OF AMERICA CORP /DE/